Physician profile
Brandi R French
NPI 1659368413
$3,181.48
in general payments reported to CMS, 2019-2025
14 companies · $1,806 in 2025
The $1,806 reported for 2025 was more than what 77% of Vascular Neurology providers received nationally (typical 2025 total: $360).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $322 · 2020: $29.80 · 2021: $241 · 2022: $381 · 2023: $330 · 2024: $71.26 · 2025: $1,806.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $1,128 · Food and Beverage: $1,080.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $1,127.51 |
| Food and Beverage | $1,080.17 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $2,181.11 | 2021-2025 | Linq II |
| Penumbra, INC. | $302.87 | 2019-2022 | |
| Siemens Medical Solutions USA, INC. | $136.16 | 2019 | |
| Stryker Corporation | $118.44 | 2021 | |
| Imperative Care, INC | $89.64 | 2023 | Tracstar Large Distal Platform |
| Amneal Pharmaceuticals LLC | $71.26 | 2024 | |
| Abbott Laboratories | $50.64 | 2021 | |
| Inspire Medical Systems, INC. | $49.18 | 2025 | Inspire |
| Medtronic Vascular, INC. | $48.53 | 2019-2020 | |
| Bayer Healthcare Pharmaceuticals INC. | $40.00 | 2023 | |
| Boston Scientific Corporation | $39.02 | 2022 | |
| Abbvie INC. | $28.10 | 2022 | |
| Genentech USA, INC. | $14.76 | 2021 | |
| Supernus Pharmaceuticals, INC. | $11.77 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Brandi French listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.